Acceleron Pharma Inc (XLRN)

178.75
0.93 0.52
NASDAQ
Prev Close 179.68
Open 179.85
Day Low/High 177.06 / 179.85
52 Wk Low/High 108.82 / 189.99
Volume 7.88M
Exchange NASDAQ
Div & Yield N.A. (N.A)

FibroGen Feedback

I continue to get good feedback with regard to FibroGen.   The above is part of a publication on myelodysplastic syndrome.  I would note that Acceleron is being acquired by Merck for $11 billion.  Acceleron has a drug on market which treats 15%-20% ...

Glimmers of Hope in the Biotech Realm as M&A Activity Picks Up

Glimmers of Hope in the Biotech Realm as M&A Activity Picks Up

A recent trio of acquisition deals indicates the doldrums in the sector may be over.

Don't Own Merck Stock Yet? Here's My Prescription

Don't Own Merck Stock Yet? Here's My Prescription

I am in this one for the medium to long term.

Acceleron Pharma Looks Poised to Continue Bull Run in 2021

Acceleron Pharma Looks Poised to Continue Bull Run in 2021

The biopharma company's stock has built a nice base, which suggests the shares could keep moving significantly higher in the coming months.

Acceleron Cut to Sell at Goldman Sachs

Acceleron Pharma Is Ready to Rally Ahead of Earnings

Acceleron Pharma Is Ready to Rally Ahead of Earnings

Here's how to trade XLRN stock right now.

BioTech IPOs With Big Partners

BioTech IPOs With Big Partners

These biotech IPOs all have collaborations with big name companies says Equities.com Francis Gaskins.